… This section details the advancements and challenges in miRNA delivery to the pulmonary
vasculature, as we continue our efforts to refine translation of miRNA-based therapies for …

… This trend reiterates the importance of focus on pulmonary hypertension before end-…
advances set the framework for a new and potentially transformative era in pulmonary hypertension …

Pulmonary arterial hypertension (PAH) has been frequently compared with a type of malignant
disease and has an incredible number of pathogenic mechanisms similar to cancer (1–3)…

… causes and modifiers of pulmonary arterial hypertension (PAH) has … advances in our
capacity to precisely define the factors involved in PAH, and all forms of pulmonary hypertension…

… , “Molecular Research on Pulmonary Hypertension 3.0”, of … highlight recent advances in the
field of pulmonary hypertension (… Pulmonary arterial hypertension (PAH) is a chronic disease …

… In conclusion, the field of pulmonary vascular biology continues to capitalize on profound
advances in science and medicine. We anticipate that the scientific information shared with our …

… These observations have then been linked to recent advances in our understanding of
endothelial function, smooth muscle cell (SMC) electrophysiology, matrix metalloproteinase (MMP…

… For example, in the UK, the annual cost to treat a patient with advanced PAH with
bosentan (an ERA) … There are 598 ongoing clinical trials on pulmonary hypertension (clinicaltrials.gov). …

… thinking for the next 5–10 years of pulmonary hypertension (PH) research development and
to focus equally well on both basic and translational research. Kurt Stenmark and Todd Bull, …

… studies are two important components of translational research. In exploratory research, …
of pulmonary hypertension, potentially explaining the limited therapeutic advances beyond …